NBC News published a story today that shared the success of the Bionic Pancreas out-patient trials that have been recently run. The results surpassed anything the researchers had hoped for. The clinical data was recently pubiished in the New England Journal of Medicine and the lead investigators will present at the American Diabetes Association Scientific Sessions next weekend.

The story quotes the Dr. Steven Russell of Massachusetts General Hospital noting the close glycemic control achieved with the Bionic Pancreas “The system was able to bring everybody into the range that reduces complications,” Russell said. “Not just half of them. Not just three-fourths of them. Everybody.” 

No one had a hypoglycemic crash. “There’s no current standard-of-care therapy that could match the results we saw," Professor Ed Damiano of Boston University said.

The Bionic Pancreas mobile-device platform, the brainchild of Professor Ed Damiano, consists of closed-loop algorithms running on the iPhone, integrating the Dexcom G4 Platinum continuous glucose monitoring (CGM) system with Tandem Diabetes t:slim infusion pumps. The technology was developed in a multi-body partnership including Egret Technologies.